Lyme borreliosis - The utility of improved real-time PCR assay in the detection of Borrelia Burgdorferi infections

Advances in Clinical and Experimental Medicine

Volumn 24, Issue 4, 2015, Pages 663-670

  Bil Lula, Iwona ^a   Matuszek, Patryk ^b   Pfeiffer, Thomas ^b   Woźniak, Mieczysław ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Institute of Experimental Immunology   (Germany)

Author keywords

Borreliosis; RQ PCR; Whole blood

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; BACTERIAL DNA; BACTERIUM ANTIBODY; GENETIC MARKER; RNA 16S;

ADULT; AGED; ARTICLE; BACTERIAL LOAD; BACTERIUM DETECTION; BLOOD SAMPLING; BORRELIA BURGDORFERI; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; IMMUNOBLOTTING; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BLOOD; CALIBRATION; CLASSIFICATION; COMPARATIVE STUDY; GENETIC MARKER; GENETICS; IMMUNOLOGY; INCIDENCE; MICROBIOLOGY; POLAND; PROCEDURES; REPRODUCIBILITY; RIBOTYPING; SEROLOGY; STANDARD; STANDARDS;

ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; CALIBRATION; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC MARKERS; HUMANS; INCIDENCE; LYME DISEASE; POLAND; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RIBOTYPING; RNA, RIBOSOMAL, 16S; SEROLOGIC TESTS;

EID: 84945133391     PISSN: 18995276     EISSN: 24512680     Source Type: Journal    
DOI: 10.17219/acem/28625     Document Type: Article

References (37)

1. Steere AC: Lyme disease. N Engl J Med 2001, 345, 115-125.
2. Žákovská A, Nejezchlebová H, Bartoňková N, Rašovská T, Kučerová H, Norek A, Ovesná P: Activity of the tick Ixodes ricinus monitored in a suburban park in Brno, Czech Republic, in association with the evaluation of selected repellents. J Vector Ecol 2013, 38, 295-300.
3. Stinco G, Ruscio M, Bergamo S., Trotter D, Patrone P: Clinical features of 705 Borrelia burgdorferi seropositive patients in an endemic area of northern Italy. Sci World J 2014, 4, 414-505.
4. Mosshammer D, Hlobil H, Joos S., Reichert W: A patient with Lyme arthritis presenting in general practice. Practitioner 2013, 257, 25-27.
5. Esposito S, Bosis S, Sabatini C., Tagliaferri L, Principi N: Borrelia burgdorferi infection and Lyme disease in children. Int J Infect Dis 2013, 17, 153-158.
6. Grygorczuk S, Péter O, Kondrusik M., Moniuszko A, Zajkowska J, Dunaj J., Żukiewicz-Sobczak W, Pancewicz S: Assessment of the frequency of different Borrelia burgdorferi sensu lato species in patients with Lyme borreliosis from north-east Poland by studying preferential serologic response and DNA isolates. Ann Agric Environ Med 2013, 20, 21-29.
7. Rauter C, Hartung T: Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis. Appl Environ Microbiol 2005, 71, 7203-7216.
8. Hanincova K, Mukherjee P, Ogden N.H., Margos G., Wormser GP, Reed KD, Meece JK, Vandermause M.F., Schwartz I: Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One 2013, 8, e73066.
9. Aguero-Rosenfeld M.E., Wang G, Schwartz I., Wormser GP: Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005, 18, 484-509.
10. Stanek G, Strie F: Lyme borreliosis. Lancet 2003, 362, 1639-1647.
11. Fawcett PT, Rose CD, Maduskuie V: Long-term effects of immunization with recombinant lipoprotein outer surface protein a on serologic test for Lyme disease. Clin Diagn Lab Immunol 2004, 11, 808-810.
12. Smith RP, Schoen RT, Rahn D.W., Sikand VK, Nowakowski J, Parenti DL, Holman M.S., Persing DH, Steere AC: Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 2002, 136, 421-428.
13. Wormser GP, Nadelman RB, Nowakowski J, Schwartz I: Asymptomatic Borrelia burgdorferi infection. Med Hypotheses 2001, 57, 435-438.
14. Steere AC, McHugh G, Damle N., Sikand VK: Prospective study of serologic tests for Lyme disease. Clin Infect Dis 2008, 47, 188-195.
15. Liu ZY, Hao Q, Hou X.X., Jiang Y., Geng Z, Wu YM, Wan KL: A study of the technique of Western blot for diagnosis of Lyme disease caused by Borrelia afzelii in China. Biomed Environ Sci 2013, 26, 190-200.
16. Hinterseher I, Gäbel G, Corvinus F., Lück C, Saeger H.D., Bergert H., Tromp G, Kuivaniemi H: Presence of Borrelia burgdorferi sensu lato antibodies in the serum of patients with abdominal aortic aneurysms. Eur J Clin Microbiol Infect Dis 2012, 31, 781-789.
17. Robertson J, Guy E, Andrews N., Wilske B, Anda P, Granstrom M., Hauser U, Moosmann Y, Sambri V., Schellekens J, Stanek G, Gray J: A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000, 38, 2097-2102.
18. Bergmann AR, Schmidt BL, Derler A.M., Aberer E: Importance of sample preparation for molecular diagnosis of Lyme borreliosis from urine. J Clin Microbiol 2002, 40, 4581-4584.
19. Liveris D, Wang G, Girao G., Byrne DW, Nowakowski J, McKenna D, Nadelman R., Wormser GP, Schwartz I: Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol 2002, 40, 1249-1253.
20. Lynn I, Reed KD, Mitchell PD: A LightCycler TaqMan assay for detection of Borrelia burgdorferi sensu lato in clinical samples. Diagn Microb Infect Dis 2007, 57, 137-143.
21. Mackay IM, Arden KE, Nitsche A: Real-time PCR in virology. Nucleic Acids Res 2002, 30, 1292-1305.
22. Radzisauskiené D, Ambrozaitis A, Marciuskienè E: Delayed diagnosis of Lyme neuroborreliosis presenting with abducens neuropathy without intrathecal synthesis of Borrelia antibodies. Medicina (Kaunas) 2013, 49, 89-94.
23. Schwan TG, Piesman J: Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 2000, 38, 382-388.
24. Fomenko NV, Livanova NN, Romanova E.V., Karavaeva IuIu, Panov V V, Chernousova NIa: Detection of DNA of borrelia circulating in Novosibirsk region. Zh Mikrobiol Epidemiol Immunobiol 2006, 7, 22-28.
25. Magnarelli LA, Williams SC, Norris S.J., Fikrig E: Serum antibodies to Borrelia burgdorferi, Anaplasma phagocy-tophilum, and Babesia microti in recaptured white-footed mice. J Wildl Dis 2013, 49, 294-302.
26. Rawlins ML, Gerstner C, Hill H.R., Litwin CM: Evaluation of a Western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi. Clin Diagn Lab Immunol 2005, 12, 1269-1274.
27. Magnarelli LA, Fikrig E, Padula S.J., Anderson JF, Flavell RA: Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol 1996, 34, 237-240.
28. Fikrig E, Feng W, Aversa J., Schoen RT, Flavell RA: Differential expression of Borrelia burgdorferi genes during erythema migrans and Lyme arthritis. J Infect Dis 1998, 178, 1198-1201.
29. de Silva A.M., Fikrig E: Borrelia burgdorferi genes selectively expressed in ticks and mammals. Parasitol Today 1997, 13, 267-270.
30. Ohnishi J, Piesman J, de Silva AM: Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 2001, 98, 670-675.
31. Schwan TG, Piesman J: Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis 2002, 8, 115-121.
32. Crother TR, Champion CI, Wu X.Y., Blanco DR, Miller JN, Lovett MA: Antigenic composition of Borrelia burgdorferi during infection of SCID mice. Infect Immun 2003, 71, 3419-3428.
33. Fikrig E, Feng W, Barthold S.W., Telford III SR, Flavell RA: Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol 2000, 164, 5344-5351.
34. Hubner A, Yang X, Nolen D.M., Popova TG, Cabello FC, Norgard MV: Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc Natl Acad Sci USA 2001, 98, 12724-12729.
35. Miller JC, von Lackum K, Babb K, McAlister J.D., Stevenson B: Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle. Infect Immun 2003, 71, 6943-6952.
36. Yang X, Popova TG, Hagman K.E., Wikel SK, Schoeler GB, Caimano MJ, Radolf J.D., Norgard MV: Identification, characterization, and expression of three new members of the Borrelia burgdorferi Mlp (2.9) lipoprotein gene family. Infect Immun 1999, 67, 6008-6018.
37. Bil-Lula I., De Franceschi N, Pawlik K, Wozniak M: Improved real-time PCR assay for detection and quantification of all 54 known types of human adenoviruses in clinical samples. Med Sci Monit 2012, 18, 221-228.